Institutional Biosafety Committee
In accordance with federal regulations the Illinois Institute of Technology (IIT) has developed an Institutional Biosafety Committee (IBC) in response to the need of faculty members to conduct research utilizing recombinant DNA. The Institutional Biosafety Committee is the cornerstone of institutional oversight of recombinant DNA research.
The IIT Institutional Biosafety Committee's review also includes oversight of a variety of experimentation that involves biological materials (e.g., infectious agents) and other potentially hazardous agents (e.g., carcinogens). The IBC is chaired by Ben Stark Ph.D. of BCPS starkb@iit.edu.
If you should have any questions, please contact the Office of Research Compliance and Proposal Development at 312-567-7141 or at ibc@iit.edu.
2010 IBC Protocol Submission Deadlines:
5 pm -- Monday March 22, 2010
5 pm -- Monday June 21, 2010
5 pm -- Monday September 20, 2010
More information about biosafety and federal requirements:
Office of Biotechnology Activities
NIH Guidelines
If your research involves human participation, animal studies, or rDNA, biological materials, or potentially hazardous agents approval is necessary by one of these boards.
- Institutional Review Board (Human Subjects)
- Institutional Animal Care and Use Committee (Animal Subjects)
- Institutional Biosafety (Biological Materials; rDNA); see above
Office of Research Compliance and Proposal Development
Main Building, Room 301,
312.567.7141
orcpd@iit.edu